Neurosense Therapeutics Stock Price History

NRSN Stock  USD 0.90  0.02  2.17%   
If you're considering investing in Neurosense Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neurosense Therapeutics stands at 0.90, as last reported on the 24th of November, with the highest price reaching 0.96 and the lowest price hitting 0.85 during the day. Neurosense Therapeutics appears to be very risky, given 3 months investment horizon. Neurosense Therapeutics has Sharpe Ratio of 0.0559, which conveys that the firm had a 0.0559% return per unit of risk over the last 3 months. We have found thirty technical indicators for Neurosense Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Neurosense Therapeutics' Downside Deviation of 4.87, mean deviation of 3.78, and Risk Adjusted Performance of 0.0459 to check out if our risk estimates are consistent with your expectations.
  
At this time, Neurosense Therapeutics' Common Stock Shares Outstanding is very stable compared to the past year. As of the 24th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 5.3 M, though Total Stockholder Equity is likely to grow to (1.8 M). . As of the 24th of November 2024, Price Earnings Ratio is likely to drop to -1.11. In addition to that, Price Book Value Ratio is likely to grow to -5.43. Neurosense Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0559

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsNRSN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.43
  actual daily
48
52% of assets are more volatile

Expected Return

 0.3
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Neurosense Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurosense Therapeutics by adding it to a well-diversified portfolio.
Price Book
4.1496
Book Value
(0.09)
Enterprise Value
16.7 M
Enterprise Value Ebitda
(1.16)
Shares Float
13.5 M

Neurosense Therapeutics Stock Price History Chart

There are several ways to analyze Neurosense Stock price data. The simplest method is using a basic Neurosense candlestick price chart, which shows Neurosense Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 13, 20241.35
Lowest PriceAugust 30, 20240.89

Neurosense Therapeutics November 24, 2024 Stock Price Synopsis

Various analyses of Neurosense Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Neurosense Stock. It can be used to describe the percentage change in the price of Neurosense Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Neurosense Stock.
Neurosense Therapeutics Price Daily Balance Of Power(0.18)
Neurosense Therapeutics Price Rate Of Daily Change 0.98 
Neurosense Therapeutics Price Action Indicator(0.01)

Neurosense Therapeutics November 24, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Neurosense Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Neurosense Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Neurosense Stock and then apply it to test your longer-term investment strategies against Neurosense.

Neurosense Stock Price History Data

The price series of Neurosense Therapeutics for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 0.64 with a coefficient of variation of 15.08. The daily prices for the period are spread out with arithmetic mean of 1.16. The median price for the last 90 days is 1.22.
OpenHighLowCloseVolume
11/24/2024
 0.92  0.96  0.85  0.90 
11/22/2024 0.92  0.96  0.85  0.90  117,557 
11/21/2024 0.98  1.02  0.91  0.92  143,515 
11/20/2024 1.11  1.12  0.97  0.99  195,059 
11/19/2024 1.15  1.19  1.11  1.12  167,805 
11/18/2024 1.25  1.26  1.14  1.18  121,022 
11/15/2024 1.28  1.28  1.19  1.23  178,762 
11/14/2024 1.30  1.33  1.27  1.30  50,930 
11/13/2024 1.35  1.35  1.27  1.33  111,044 
11/12/2024 1.31  1.35  1.30  1.33  48,211 
11/11/2024 1.30  1.35  1.30  1.32  121,328 
11/08/2024 1.30  1.30  1.26  1.29  23,982 
11/07/2024 1.31  1.34  1.23  1.29  77,388 
11/06/2024 1.29  1.30  1.24  1.28  100,415 
11/05/2024 1.25  1.25  1.21  1.25  72,999 
11/04/2024 1.26  1.34  1.14  1.23  388,593 
11/01/2024 1.30  1.38  1.23  1.27  492,402 
10/31/2024 1.31  1.32  1.12  1.25  361,975 
10/30/2024 1.32  1.34  1.29  1.30  38,221 
10/29/2024 1.39  1.40  1.27  1.34  111,917 
10/28/2024 1.30  1.40  1.29  1.35  810,726 
10/25/2024 1.25  1.32  1.24  1.27  331,765 
10/24/2024 1.14  1.24  1.05  1.21  312,395 
10/23/2024 1.11  1.17  1.11  1.15  34,040 
10/22/2024 1.11  1.15  1.07  1.15  26,070 
10/21/2024 1.08  1.10  1.04  1.10  55,785 
10/18/2024 1.14  1.15  1.05  1.07  60,942 
10/17/2024 1.00  1.10  0.96  1.10  100,307 
10/16/2024 0.97  1.00  0.92  0.98  143,877 
10/15/2024 1.16  1.22  0.95  0.96  388,577 
10/14/2024 1.09  1.12  1.03  1.09  148,119 
10/11/2024 1.22  1.24  1.09  1.13  263,292 
10/10/2024 1.19  1.22  1.10  1.22  90,455 
10/09/2024 1.24  1.25  1.09  1.22  221,439 
10/08/2024 1.26  1.27  1.22  1.22  30,464 
10/07/2024 1.23  1.29  1.21  1.25  74,393 
10/04/2024 1.24  1.28  1.22  1.26  50,187 
10/03/2024 1.19  1.28  1.19  1.22  48,584 
10/02/2024 1.20  1.24  1.20  1.21  27,884 
10/01/2024 1.23  1.23  1.17  1.22  65,843 
09/30/2024 1.27  1.37  1.24  1.27  64,972 
09/27/2024 1.30  1.30  1.25  1.28  64,438 
09/26/2024 1.20  1.28  1.11  1.27  106,077 
09/25/2024 1.33  1.33  1.17  1.20  185,650 
09/24/2024 1.26  1.29  0.90  1.25  802,251 
09/23/2024 1.29  1.32  1.26  1.30  61,212 
09/20/2024 1.31  1.35  1.20  1.30  93,373 
09/19/2024 1.39  1.39  1.31  1.35  67,864 
09/18/2024 1.33  1.37  1.31  1.35  77,287 
09/17/2024 1.35  1.42  1.31  1.34  125,676 
09/16/2024 1.25  1.46  1.25  1.34  334,495 
09/13/2024 1.35  1.35  1.19  1.35  196,729 
09/12/2024 1.28  1.35  1.22  1.29  316,417 
09/11/2024 1.15  1.31  1.06  1.22  488,294 
09/10/2024 1.12  1.18  1.05  1.16  255,007 
09/09/2024 0.96  1.14  0.94  1.11  713,544 
09/06/2024 0.94  0.94  0.88  0.94  94,085 
09/05/2024 0.95  0.97  0.93  0.95  81,688 
09/04/2024 0.98  0.99  0.93  0.97  102,253 
09/03/2024 0.92  0.99  0.88  0.98  592,151 
08/30/2024 0.73  0.95  0.73  0.89  1,360,765 

About Neurosense Therapeutics Stock history

Neurosense Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurosense is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurosense Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurosense Therapeutics stock prices may prove useful in developing a viable investing in Neurosense Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding13.6 M14.3 M
Net Loss-3.6 M-3.8 M

Neurosense Therapeutics Stock Technical Analysis

Neurosense Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Neurosense Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurosense Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Neurosense Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Neurosense Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Neurosense Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Neurosense to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Neurosense Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neurosense Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurosense Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurosense Therapeutics Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Return On Assets
(1.51)
Return On Equity
(4.95)
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.